Fundraising FoxCatalyze Capital
Venture capitalAmsterdam · Seed–Series A · 8 people tracked
Find your way into Catalyze Capital
Sign up to see every warm intro you have to Catalyze Capital
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Catalyze Capital team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
Catalyze Capital invests in companies that apply science and technology to create positive impact for people and the planet. Leveraging its expertise, the fund concentrates on life science, sustainable, and deep tech innovations. It provides up to €1.5 million to small and medium-sized enterprises registered in Europe, targeting companies and academic spin-offs at the Seed and Series A stages, and supports them as they grow and build value.
Source: firm website, verified Aug 16, 2026.
Team · 8 people
from the firm's website
What they invest in
from 4 of 5 portfolio companiesBiotech ×3Medical Devices ×3Digital Health ×2AI & Machine Learning ×1Climate Tech ×1Consumer ×1FemTech ×1FoodTech ×1
HQs:Sweden×2Germany×1United States×1
Investments · 5 tracked
founders shown can be your intro path
AdrenoMed AG is a clinical-stage biopharmaceutical company developing Enibarcimab (formerly Adrecizumab), a first-in-class antibody targeting the peptide Adrenomedullin to restore vascular integrity in critically ill patients, with septic shock as its lead indication.
BiotechHealthtechMedical DevicesHennigsdorf, DE
Gerald Moeller(Co-founder and former CEO of AdrenoMed; Supervisory Board member)inRichard Jones(Chief Executive Officer (CEO))inDavid Germonpré(Chief Financial Officer (CFO))in
Co-investorsBrandenburg KapitalHBM Healthcare InvestmentsHBM PartnersVU Venture Partners
Gesynta Pharma is a pharmaceutical company developing non-hormonal, anti-inflammatory drug candidates that inhibit the mPGES-1 enzyme, with a lead program in endometriosis.
BiotechDigital HealthFemTechMedical DevicesStockholm, SE
Patric Stenberg(Founder)Gunilla Ekström(Founder)in
Co-investorsAmboy Street VenturesForeground CapitalHadean VenturesHealthCapIndustrifondenXGEN Venture
Melt&Marble uses precision fermentation, microbial metabolic engineering, and synthetic biology to produce fats and ingredients aimed at creating more sustainable food products.
BiotechClimate TechConsumerFoodTechNew MaterialsGothenburg, SE
Anastasia Krivoruchko(Co-founder & CEO)inFlorian David(Co-founder & CSO)inJens Nielsen(Co-founder & Chairman of the Board)inThomas Cresswell(Chief Business Officer)inTue Holdal(Chief Technology Officer)in
Co-investorsBeiersdorf Innovation FundChalmers Ventures ABIndustrifondenLever VCNordic Foodtech VCPINC
NEL develops software-driven solutions for motion analysis and diagnostics to support epilepsy patients and their physicians.
AI & Machine LearningDigital HealthMedical Devices
Co-investorsHadean VenturesMaki.vcSHS Capital
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Portfolio news
latest coverage across their companiesMelt&Marble · finsmes.com · Dec 8, 2025
Frequently asked questions
- How many investments has Catalyze Capital made?
- Catalyze Capital has 5 tracked investments, including 1 dated in the last 24 months.
- What stage does Catalyze Capital invest at?
- Catalyze Capital invests at the Seed, Series A stages.
- What is Catalyze Capital's typical check size?
- Catalyze Capital typically writes checks of $1.6M.
- What sectors does Catalyze Capital focus on?
- Catalyze Capital focuses on Biotech, Cleantech, Climate Tech, Deep Tech, Impact & Social Good.
- Where is Catalyze Capital located?
- Catalyze Capital is headquartered in Amsterdam, NL.
- Who does Catalyze Capital co-invest with?
- Catalyze Capital most often shares deals with Hadean Ventures, Industrifonden, Amboy Street Ventures, among 15 tracked co-investors.
Similar investors
Innovestor is a Finnish investment manager active in venture capital, real estate, and energy storage, and also provides corporate venturing services.
Octopus Ventures is a founder-focused European venture capital firm that backs mission-driven startups across seven core sectors, investing from idea stage through growth with a focus on pre-seed to Series A.
EMV Capital is a deep tech and life sciences venture capital investment group that invests in, strengthens, and manages early-stage companies with attractive intellectual property. It uses a capital-efficient model combining syndicated investments, balance sheet stakes, and fund deployment.
EUREKA! Venture SGR is an independent Italian venture capital asset management company focused exclusively on deep tech investments, drawing on expertise in scientific research, technology transfer, and venture capital.
ISV (Impact Science Ventures) is an early-stage investor and company builder focused on industrial innovation, backing startups that commercialize scientific breakthroughs to disrupt large global markets while advancing climate and sustainability goals.